LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway

被引:15
|
作者
Li, Jiandong [1 ]
Xu, Xiaohu [1 ]
Zhang, Dandan [1 ]
Lv, Han [1 ]
Lei, Xin [1 ]
机构
[1] Shenzhen Longhua Dist Cent Hosp, Dept Stomatol, Shenzhen 518000, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2021年 / 14卷
关键词
oral squamous cell carcinoma; LHFPL3-AS1; miR-362-5p; CHSY1; CANCER METASTASIS; PROLIFERATION; INVASION; AXIS;
D O I
10.2147/OTT.S298679
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Oral squamous cell carcinoma (OSCC) is a common oral cancer. The current study aims to elucidate the potential roles of long noncoding RNA (lncRNA) LHFPL3-AS1 in OSCC development. Methods: Gene expression was measured by qRT-PCR in tumor tissues and cell lines. Loss-of-function assays were performed to analyze the effects of LHFPL3-AS1 on malignant behaviors. Bioinformatics analysis was conducted to explore the downstream signaling pathway of LHFPL3-AS1 in OSCC. Results: LHFPL3-AS1 was highly expressed in OSCC tissues and cell lines. LHFPL3-AS1 was upregulated in cisplatin-resistant tumor cell lines. LHFPL3-AS1 level was correlated with survival rate. LHFPL3-AS1 knockdown suppressed OSCC proliferation, migration and invasion. LHFPL3-AS1 downregulation reduced cisplatin resistance of OSCC cells. LHFPL3-AS1 was the competing endogenous RNA (ceRNA) for miR-194-5p to enhance CHSY1 expression. Conclusion: LHFPL3-AS1/miR-362-5p/CHSY1 signaling pathway plays essential roles in regulating OSCC development and cisplatin resistance.
引用
收藏
页码:2293 / 2300
页数:8
相关论文
共 50 条
  • [1] LncRNA FENDRR Upregulation Promotes Hepatic Carcinoma Cells Apoptosis By Targeting miR-362-5p Via NPR3 and p38-MAPK Pathway
    Qian, Guangyu
    Jin, Xiaoyan
    Zhang, Louwei
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2020, 35 (09) : 629 - 639
  • [2] Hsa_circ_0005050 regulated the progression of oral squamous cell carcinoma via miR-487a-3p/CHSY1 axis
    Chen, Xubin
    Chen, Qiaojiang
    Zhao, Chen
    Lu, Zhiqi
    JOURNAL OF DENTAL SCIENCES, 2023, 18 (01) : 282 - 294
  • [3] LncRNA XIST promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by downregulating miR-27b-3p
    Ma, S-Q
    Wang, Y-C
    Li, Y.
    Li, X-Y
    Yang, J.
    Sheng, Y-M
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (06): : 1993 - 2001
  • [4] LncRNA LHFPL3-AS1 contributes to tumorigenesis of melanoma stem cells via the miR-181a-5p/BCL2 pathway
    Zhang, Song
    Wan, Haitao
    Zhang, Xiaobo
    CELL DEATH & DISEASE, 2020, 11 (11)
  • [5] LncRNA HOXD-AS1 promotes oral squamous cell carcinoma by sponging miR-203a-5p
    Zhang, Yuchao
    Wang, Feng
    Yu, Yang
    ORAL DISEASES, 2023, 29 (04) : 1505 - 1512
  • [6] LncRNA LHFPL3-AS1 contributes to tumorigenesis of melanoma stem cells via the miR-181a-5p/BCL2 pathway
    Song Zhang
    Haitao Wan
    Xiaobo Zhang
    Cell Death & Disease, 11
  • [7] LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
    Fang, Zheng
    Zhao, Junfang
    Xie, Weihong
    Sun, Qiang
    Wang, Haibin
    Qiao, Bin
    CANCER MEDICINE, 2017, 6 (12): : 2897 - 2908
  • [8] Exosomal lncRNA HEIH promotes cisplatin resistance in tongue squamous cell carcinoma via targeting miR-3619-5p/HDGF axis
    Wang, Xiaowei
    Yu, Huiming
    Yu, Zhifen
    Wang, Dazhao
    ACTA HISTOCHEMICA, 2020, 122 (08)
  • [9] LncRNA INHBA-AS1 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by sponging miR-143-3p
    Ma, W. -Q.
    Chen, J.
    Fang, W.
    Yang, X. -Q.
    Zhu, A.
    Zhang, D.
    Zhong, H. -L.
    Yang, B.
    Luo, Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (18) : 9240 - 9240
  • [10] lncRNA MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p
    Hou, Chao
    Wang, Xu
    Du, Bo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (02) : 978 - 984